Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Medicines.ie | Reliable & Accurate Online Medicines Information | Home page
Home Medicines Active Ingredients Companies DHPC Advanced Search Side Effect Reporting
Login
  • Home
  • Companies
  • Vifor Pharma UK Limited

Vifor Pharma UK Limited

Vifor Pharma UK Limited
  • Address:

    Point, 29 Market Street, Maidenhead, SL6 8AA, United Kingdom
  • Medical Information E-mail:

    MedicalInfo_UK@viforpharma.com
  • Telephone:

    +44 (0)1276 853 600
  • Fax:

    +44 (0)1276 452 341
  • Medical Information Direct Line:

    +44 (0)1276 853 633
  • Customer Care direct line:

    +44 (0)1276 853 633

Company products

Medicine Status Monitoring SPC PIL XPIL Legal Category Active Ingredient(s) Company
Ferinject (ferric carboxymaltose)
No Recent Update
SPC PIL No A
Ferric Carboxymaltose
Vifor Pharma UK Limited
Kapruvia
No Recent Update
SPC PIL No C
Difelikefalin
Vifor Pharma UK Limited
Tavneos
No Recent Update
SPC PIL No C
Avacopan
Vifor Pharma UK Limited
Velphoro 125 mg oral powder in sachet
No Recent Update
SPC PIL No B
Sucroferric Oxyhydroxide
Vifor Pharma UK Limited
Velphoro 500 mg chewable tablets
No Recent Update
SPC PIL No B
Sucroferric Oxyhydroxide
Vifor Pharma UK Limited
Veltassa (Patiromer)
No Recent Update
SPC PIL No B
Patiromer Sorbitex Calcium
Vifor Pharma UK Limited
Venofer (iron sucrose)
No Recent Update
SPC PIL No A
Iron Sucrose
Vifor Pharma UK Limited

Brought to you by

Irish Pharmaceutical Healthcare Association | Home page

About

  • Help
  • About
  • Contact Us

Legal

  • Privacy Statement
  • Terms & Conditions
  • Accessibility

Search

  • Medicines
  • Active Ingredients
  • Companies

Award

Pharma Industry Awards 2020, Innovation of the Year, 2nd Place
Designed by eConcept Web Solutions
Direct Healthcare Professional Communications
This medicine and its document have not been updated in the last 30 days.
Product subject to medical prescription which may not be renewed (A)
Black Inverted Triangle: This medicinal product is subject to additional monitoring.
Product subject to restricted prescription (C)
Product subject to medical prescription which may be renewed (B)